

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.26677384 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.26677384 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.99578310 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.67267388 |
| 5 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.35345095 |
| 6 | negative T cell selection (GO:0043383) | 4.33765547 |
| 7 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.30707709 |
| 8 | negative regulation of T cell mediated immunity (GO:0002710) | 4.27782850 |
| 9 | negative thymic T cell selection (GO:0045060) | 4.25161013 |
| 10 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.00409434 |
| 11 | detection of other organism (GO:0098543) | 3.91568134 |
| 12 | regulation of gamma-delta T cell activation (GO:0046643) | 3.90849322 |
| 13 | B cell receptor signaling pathway (GO:0050853) | 3.89741034 |
| 14 | positive regulation of granulocyte differentiation (GO:0030854) | 3.85752815 |
| 15 | positive regulation by symbiont of host defense response (GO:0052509) | 3.80987133 |
| 16 | modulation by symbiont of host defense response (GO:0052031) | 3.80987133 |
| 17 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.80987133 |
| 18 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.80987133 |
| 19 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.80987133 |
| 20 | modulation by symbiont of host immune response (GO:0052553) | 3.80987133 |
| 21 | cellular extravasation (GO:0045123) | 3.80777060 |
| 22 | response to interleukin-15 (GO:0070672) | 3.74736560 |
| 23 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.74530603 |
| 24 | detection of bacterium (GO:0016045) | 3.72842440 |
| 25 | valine metabolic process (GO:0006573) | 3.53031827 |
| 26 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.52612472 |
| 27 | negative regulation of cell killing (GO:0031342) | 3.52489235 |
| 28 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.52489235 |
| 29 | alpha-linolenic acid metabolic process (GO:0036109) | 3.47690942 |
| 30 | histone H3-K36 demethylation (GO:0070544) | 3.43316716 |
| 31 | positive thymic T cell selection (GO:0045059) | 3.42508791 |
| 32 | tolerance induction (GO:0002507) | 3.34172032 |
| 33 | thymic T cell selection (GO:0045061) | 3.33334397 |
| 34 | detection of external biotic stimulus (GO:0098581) | 3.31476946 |
| 35 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.29253638 |
| 36 | macrophage activation involved in immune response (GO:0002281) | 3.26971104 |
| 37 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.25387701 |
| 38 | T cell selection (GO:0045058) | 3.24393006 |
| 39 | response to muramyl dipeptide (GO:0032495) | 3.20547154 |
| 40 | cellular response to interleukin-15 (GO:0071350) | 3.19536673 |
| 41 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.17828426 |
| 42 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.15667262 |
| 43 | neutrophil activation involved in immune response (GO:0002283) | 3.13154512 |
| 44 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.12085483 |
| 45 | positive T cell selection (GO:0043368) | 3.11716978 |
| 46 | detection of molecule of bacterial origin (GO:0032490) | 3.11346004 |
| 47 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.09097429 |
| 48 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.05759976 |
| 49 | L-phenylalanine catabolic process (GO:0006559) | 3.05759976 |
| 50 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.04052376 |
| 51 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.01205928 |
| 52 | negative regulation of adaptive immune response (GO:0002820) | 2.99568079 |
| 53 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.94787198 |
| 54 | regulation of T cell tolerance induction (GO:0002664) | 2.93996948 |
| 55 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.93636787 |
| 56 | regulation of granulocyte differentiation (GO:0030852) | 2.93425741 |
| 57 | negative regulation of interleukin-12 production (GO:0032695) | 2.92446800 |
| 58 | carnitine metabolic process (GO:0009437) | 2.92340022 |
| 59 | mast cell activation (GO:0045576) | 2.90163213 |
| 60 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.89341262 |
| 61 | amino-acid betaine metabolic process (GO:0006577) | 2.88900286 |
| 62 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.86949495 |
| 63 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.86938710 |
| 64 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.86938710 |
| 65 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.86912257 |
| 66 | response to type I interferon (GO:0034340) | 2.86261027 |
| 67 | type I interferon signaling pathway (GO:0060337) | 2.86149004 |
| 68 | cellular response to type I interferon (GO:0071357) | 2.86149004 |
| 69 | microglial cell activation (GO:0001774) | 2.85596841 |
| 70 | T cell migration (GO:0072678) | 2.85179143 |
| 71 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.84740799 |
| 72 | detection of biotic stimulus (GO:0009595) | 2.84135347 |
| 73 | positive regulation of B cell differentiation (GO:0045579) | 2.82482144 |
| 74 | dendritic cell migration (GO:0036336) | 2.81550838 |
| 75 | neutrophil activation (GO:0042119) | 2.81536871 |
| 76 | positive regulation of histone deacetylation (GO:0031065) | 2.78152816 |
| 77 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.76886217 |
| 78 | positive regulation of tolerance induction (GO:0002645) | 2.76382022 |
| 79 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.75727801 |
| 80 | myeloid cell activation involved in immune response (GO:0002275) | 2.75446818 |
| 81 | interferon-gamma production (GO:0032609) | 2.74295210 |
| 82 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.73604697 |
| 83 | response to host immune response (GO:0052572) | 2.73604697 |
| 84 | respiratory burst (GO:0045730) | 2.72937976 |
| 85 | negative regulation of innate immune response (GO:0045824) | 2.72407068 |
| 86 | dendritic cell chemotaxis (GO:0002407) | 2.72208165 |
| 87 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.72156130 |
| 88 | L-phenylalanine metabolic process (GO:0006558) | 2.72156130 |
| 89 | T cell costimulation (GO:0031295) | 2.72092412 |
| 90 | T cell homeostasis (GO:0043029) | 2.71832193 |
| 91 | lymphocyte costimulation (GO:0031294) | 2.71533591 |
| 92 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.70595788 |
| 93 | leukocyte aggregation (GO:0070486) | 2.69548860 |
| 94 | negative regulation of type 2 immune response (GO:0002829) | 2.68396022 |
| 95 | 2-oxoglutarate metabolic process (GO:0006103) | 2.68170712 |
| 96 | response to host (GO:0075136) | 2.67062334 |
| 97 | response to host defenses (GO:0052200) | 2.67062334 |
| 98 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.67062334 |
| 99 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.66666055 |
| 100 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.66191427 |
| 101 | aromatic amino acid family catabolic process (GO:0009074) | 2.65821826 |
| 102 | growth hormone receptor signaling pathway (GO:0060396) | 2.64251926 |
| 103 | short-chain fatty acid metabolic process (GO:0046459) | 2.63760454 |
| 104 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.59102177 |
| 105 | regulation of B cell differentiation (GO:0045577) | 2.58989218 |
| 106 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.58977570 |
| 107 | protein carboxylation (GO:0018214) | 2.58977570 |
| 108 | lysine metabolic process (GO:0006553) | 2.58067552 |
| 109 | lysine catabolic process (GO:0006554) | 2.58067552 |
| 110 | cysteine metabolic process (GO:0006534) | 2.56673165 |
| 111 | ethanol oxidation (GO:0006069) | 2.56251438 |
| 112 | tricarboxylic acid metabolic process (GO:0072350) | 2.56209893 |
| 113 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.54917290 |
| 114 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.54917290 |
| 115 | regulation of regulatory T cell differentiation (GO:0045589) | 2.52208521 |
| 116 | activated T cell proliferation (GO:0050798) | 2.51237190 |
| 117 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.50754335 |
| 118 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.50393506 |
| 119 | bile acid biosynthetic process (GO:0006699) | 2.47900509 |
| 120 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.47744389 |
| 121 | regulation of triglyceride catabolic process (GO:0010896) | 2.45920129 |
| 122 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.44518079 |
| 123 | regulation of cholesterol homeostasis (GO:2000188) | 2.42930875 |
| 124 | creatine metabolic process (GO:0006600) | 2.42824997 |
| 125 | regulation of tolerance induction (GO:0002643) | 2.42453346 |
| 126 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.41707030 |
| 127 | Peyers patch development (GO:0048541) | 2.41619642 |
| 128 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.41619642 |
| 129 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.41068079 |
| 130 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.40905247 |
| 131 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.40905247 |
| 132 | regulation of ARF protein signal transduction (GO:0032012) | 2.37056163 |
| 133 | complement activation, alternative pathway (GO:0006957) | 2.36067674 |
| 134 | kynurenine metabolic process (GO:0070189) | 2.35491331 |
| 135 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.34887778 |
| 136 | cellular response to growth hormone stimulus (GO:0071378) | 2.34331047 |
| 137 | megakaryocyte development (GO:0035855) | 2.31510938 |
| 138 | tryptophan catabolic process (GO:0006569) | 2.30565705 |
| 139 | indole-containing compound catabolic process (GO:0042436) | 2.30565705 |
| 140 | indolalkylamine catabolic process (GO:0046218) | 2.30565705 |
| 141 | T cell receptor signaling pathway (GO:0050852) | 2.30472687 |
| 142 | fatty acid beta-oxidation (GO:0006635) | 2.29159429 |
| 143 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.28535068 |
| 144 | natural killer cell differentiation (GO:0001779) | 2.27459484 |
| 145 | lipid oxidation (GO:0034440) | 2.26956835 |
| 146 | fatty acid oxidation (GO:0019395) | 2.25659403 |
| 147 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.25402423 |
| 148 | urea cycle (GO:0000050) | 2.25344039 |
| 149 | urea metabolic process (GO:0019627) | 2.25344039 |
| 150 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.24540680 |
| 151 | positive regulation of interleukin-2 production (GO:0032743) | 2.22563527 |
| 152 | phospholipid homeostasis (GO:0055091) | 2.22144597 |
| 153 | drug transmembrane transport (GO:0006855) | 2.21949622 |
| 154 | regulation of natural killer cell differentiation (GO:0032823) | 2.21303307 |
| 155 | tryptophan metabolic process (GO:0006568) | 2.18880744 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.95557695 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.47326391 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.71572955 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.47201602 |
| 5 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 3.10037831 |
| 6 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.77826049 |
| 7 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.54079734 |
| 8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.49799326 |
| 9 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.48076233 |
| 10 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.37896545 |
| 11 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.36617005 |
| 12 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.33257110 |
| 13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.32979953 |
| 14 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.04179938 |
| 15 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.04046444 |
| 16 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.02996264 |
| 17 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.01189948 |
| 18 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.00688158 |
| 19 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.99136018 |
| 20 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.87909101 |
| 21 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.86387135 |
| 22 | MYB_26560356_Chip-Seq_TH2_Human | 1.85637641 |
| 23 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.82874317 |
| 24 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.82870217 |
| 25 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.80223670 |
| 26 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.76563864 |
| 27 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.75773427 |
| 28 | MAF_26560356_Chip-Seq_TH1_Human | 1.71606402 |
| 29 | GATA1_22025678_ChIP-Seq_K562_Human | 1.69345848 |
| 30 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.66668613 |
| 31 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.66541271 |
| 32 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63678214 |
| 33 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.62473819 |
| 34 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.59549079 |
| 35 | MYB_26560356_Chip-Seq_TH1_Human | 1.58450104 |
| 36 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.50164160 |
| 37 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.47977450 |
| 38 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.47284532 |
| 39 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.47205964 |
| 40 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.44497259 |
| 41 | SPI1_23127762_ChIP-Seq_K562_Human | 1.42868106 |
| 42 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.42306194 |
| 43 | UTX_26944678_Chip-Seq_JUKART_Human | 1.37076531 |
| 44 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.35878603 |
| 45 | GATA1_19941826_ChIP-Seq_K562_Human | 1.34790989 |
| 46 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.31296614 |
| 47 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.29552062 |
| 48 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.29138876 |
| 49 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.26415219 |
| 50 | GATA2_19941826_ChIP-Seq_K562_Human | 1.25237085 |
| 51 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.25184814 |
| 52 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.24862928 |
| 53 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.24155807 |
| 54 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.23649814 |
| 55 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.22970566 |
| 56 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.22415167 |
| 57 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.18011643 |
| 58 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.14636846 |
| 59 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.12595216 |
| 60 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.12565298 |
| 61 | MYC_22102868_ChIP-Seq_BL_Human | 1.12458845 |
| 62 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.12121209 |
| 63 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12057161 |
| 64 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11172568 |
| 65 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.10804985 |
| 66 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.10462798 |
| 67 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.10006706 |
| 68 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.09035244 |
| 69 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.08858939 |
| 70 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.08565522 |
| 71 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07812039 |
| 72 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.06907155 |
| 73 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06729547 |
| 74 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.04838352 |
| 75 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.04613028 |
| 76 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.04414432 |
| 77 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.03675769 |
| 78 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.03564865 |
| 79 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.03557176 |
| 80 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.02898596 |
| 81 | GATA3_26560356_Chip-Seq_TH2_Human | 1.02277816 |
| 82 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.00871996 |
| 83 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99435060 |
| 84 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.98641788 |
| 85 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98379928 |
| 86 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.98241238 |
| 87 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.97170823 |
| 88 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96030806 |
| 89 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.94284598 |
| 90 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.94025964 |
| 91 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.93851873 |
| 92 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.92113590 |
| 93 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92059835 |
| 94 | RXR_22108803_ChIP-Seq_LS180_Human | 0.91180915 |
| 95 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.90787274 |
| 96 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.90657273 |
| 97 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90538194 |
| 98 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.88727918 |
| 99 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.88727918 |
| 100 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.87304399 |
| 101 | MAF_26560356_Chip-Seq_TH2_Human | 0.87018431 |
| 102 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.84829807 |
| 103 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.83849707 |
| 104 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.83807509 |
| 105 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.83664918 |
| 106 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83562798 |
| 107 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.83467488 |
| 108 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.82144695 |
| 109 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.81535289 |
| 110 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.80858266 |
| 111 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.80606650 |
| 112 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.79836627 |
| 113 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.79744326 |
| 114 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.78426098 |
| 115 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77124786 |
| 116 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.76411260 |
| 117 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.75431518 |
| 118 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.74440582 |
| 119 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.73073181 |
| 120 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.72364843 |
| 121 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.71085218 |
| 122 | * ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.70625354 |
| 123 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.68828041 |
| 124 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.66073325 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 3.23880371 |
| 2 | MP0005360_urolithiasis | 2.81879749 |
| 3 | MP0005365_abnormal_bile_salt | 2.81464900 |
| 4 | MP0000685_abnormal_immune_system | 2.79978234 |
| 5 | MP0002166_altered_tumor_susceptibility | 2.79069334 |
| 6 | MP0003300_gastrointestinal_ulcer | 2.76922796 |
| 7 | MP0001835_abnormal_antigen_presentation | 2.61528651 |
| 8 | MP0005671_abnormal_response_to | 2.59989765 |
| 9 | MP0003763_abnormal_thymus_physiology | 2.51743698 |
| 10 | MP0005085_abnormal_gallbladder_physiolo | 2.35508860 |
| 11 | MP0001873_stomach_inflammation | 2.28128872 |
| 12 | MP0003252_abnormal_bile_duct | 2.26024394 |
| 13 | MP0004130_abnormal_muscle_cell | 2.21490986 |
| 14 | MP0002138_abnormal_hepatobiliary_system | 2.18911797 |
| 15 | MP0005387_immune_system_phenotype | 2.17430959 |
| 16 | MP0001790_abnormal_immune_system | 2.17430959 |
| 17 | MP0008875_abnormal_xenobiotic_pharmacok | 2.11688856 |
| 18 | MP0001800_abnormal_humoral_immune | 2.10330885 |
| 19 | MP0008260_abnormal_autophagy | 2.01706472 |
| 20 | MP0004381_abnormal_hair_follicle | 1.93510376 |
| 21 | MP0010329_abnormal_lipoprotein_level | 1.91070714 |
| 22 | MP0002006_tumorigenesis | 1.82322389 |
| 23 | MP0009333_abnormal_splenocyte_physiolog | 1.80874066 |
| 24 | MP0009840_abnormal_foam_cell | 1.79724452 |
| 25 | MP0005464_abnormal_platelet_physiology | 1.73398857 |
| 26 | MP0006082_CNS_inflammation | 1.72360912 |
| 27 | MP0002723_abnormal_immune_serum | 1.71299905 |
| 28 | MP0009780_abnormal_chondrocyte_physiolo | 1.67486484 |
| 29 | MP0005025_abnormal_response_to | 1.67411384 |
| 30 | MP0003828_pulmonary_edema | 1.67361642 |
| 31 | MP0003690_abnormal_glial_cell | 1.67229737 |
| 32 | MP0005000_abnormal_immune_tolerance | 1.66359995 |
| 33 | MP0002452_abnormal_antigen_presenting | 1.65796061 |
| 34 | MP0001853_heart_inflammation | 1.65790731 |
| 35 | MP0002420_abnormal_adaptive_immunity | 1.65487413 |
| 36 | MP0002419_abnormal_innate_immunity | 1.63465970 |
| 37 | MP0001819_abnormal_immune_cell | 1.62376886 |
| 38 | MP0003724_increased_susceptibility_to | 1.59290147 |
| 39 | MP0004947_skin_inflammation | 1.57085482 |
| 40 | MP0009785_altered_susceptibility_to | 1.56464329 |
| 41 | MP0010155_abnormal_intestine_physiology | 1.51038187 |
| 42 | MP0003436_decreased_susceptibility_to | 1.50794989 |
| 43 | MP0005451_abnormal_body_composition | 1.47519618 |
| 44 | MP0004883_abnormal_blood_vessel | 1.44353168 |
| 45 | MP0003183_abnormal_peptide_metabolism | 1.43633302 |
| 46 | MP0002398_abnormal_bone_marrow | 1.43581217 |
| 47 | MP0000609_abnormal_liver_physiology | 1.42906697 |
| 48 | MP0003303_peritoneal_inflammation | 1.42778804 |
| 49 | MP0003191_abnormal_cellular_cholesterol | 1.41440652 |
| 50 | MP0005310_abnormal_salivary_gland | 1.40529967 |
| 51 | MP0001666_abnormal_nutrient_absorption | 1.39559317 |
| 52 | MP0000858_altered_metastatic_potential | 1.37363696 |
| 53 | MP0002009_preneoplasia | 1.36911813 |
| 54 | MP0005332_abnormal_amino_acid | 1.34671796 |
| 55 | MP0000716_abnormal_immune_system | 1.34544429 |
| 56 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.34243952 |
| 57 | MP0003866_abnormal_defecation | 1.32537550 |
| 58 | MP0001845_abnormal_inflammatory_respons | 1.28533868 |
| 59 | MP0002118_abnormal_lipid_homeostasis | 1.28478575 |
| 60 | MP0009384_cardiac_valve_regurgitation | 1.27862102 |
| 61 | MP0002132_abnormal_respiratory_system | 1.26867500 |
| 62 | MP0003868_abnormal_feces_composition | 1.25802382 |
| 63 | MP0003045_fibrosis | 1.23994324 |
| 64 | MP0000465_gastrointestinal_hemorrhage | 1.23309871 |
| 65 | MP0009764_decreased_sensitivity_to | 1.22521326 |
| 66 | MP0000689_abnormal_spleen_morphology | 1.21170736 |
| 67 | MP0008469_abnormal_protein_level | 1.20242241 |
| 68 | MP0000920_abnormal_myelination | 1.16114443 |
| 69 | MP0002396_abnormal_hematopoietic_system | 1.15985042 |
| 70 | MP0004510_myositis | 1.15656351 |
| 71 | MP0005058_abnormal_lysosome_morphology | 1.15611171 |
| 72 | MP0002405_respiratory_system_inflammati | 1.13436308 |
| 73 | MP0003172_abnormal_lysosome_physiology | 1.13400349 |
| 74 | MP0002722_abnormal_immune_system | 1.13338436 |
| 75 | MP0002928_abnormal_bile_duct | 1.13234090 |
| 76 | MP0003656_abnormal_erythrocyte_physiolo | 1.09253778 |
| 77 | MP0003075_altered_response_to | 1.08146484 |
| 78 | MP0008961_abnormal_basal_metabolism | 1.07974460 |
| 79 | MP0005670_abnormal_white_adipose | 1.06864025 |
| 80 | MP0002933_joint_inflammation | 1.05430322 |
| 81 | MP0003806_abnormal_nucleotide_metabolis | 1.03517477 |
| 82 | MP0003279_aneurysm | 1.01567925 |
| 83 | MP0002429_abnormal_blood_cell | 1.00645029 |
| 84 | MP0000604_amyloidosis | 0.99562934 |
| 85 | MP0005319_abnormal_enzyme/_coenzyme | 0.99405442 |
| 86 | MP0005164_abnormal_response_to | 0.98970273 |
| 87 | MP0001533_abnormal_skeleton_physiology | 0.97969559 |
| 88 | MP0000703_abnormal_thymus_morphology | 0.97948563 |
| 89 | MP0002148_abnormal_hypersensitivity_rea | 0.97603174 |
| 90 | MP0003091_abnormal_cell_migration | 0.97128381 |
| 91 | MP0009278_abnormal_bone_marrow | 0.96255762 |
| 92 | MP0009643_abnormal_urine_homeostasis | 0.94507308 |
| 93 | MP0002998_abnormal_bone_remodeling | 0.93254808 |
| 94 | MP0004808_abnormal_hematopoietic_stem | 0.93184250 |
| 95 | MP0005083_abnormal_biliary_tract | 0.92680648 |
| 96 | MP0000569_abnormal_digit_pigmentation | 0.88966727 |
| 97 | MP0009763_increased_sensitivity_to | 0.87131451 |
| 98 | MP0000015_abnormal_ear_pigmentation | 0.84117509 |
| 99 | MP0005166_decreased_susceptibility_to | 0.83498883 |
| 100 | MP0000249_abnormal_blood_vessel | 0.81843514 |
| 101 | MP0004484_altered_response_of | 0.81675272 |
| 102 | MP0008057_abnormal_DNA_replication | 0.79857906 |
| 103 | MP0001545_abnormal_hematopoietic_system | 0.79841993 |
| 104 | MP0005397_hematopoietic_system_phenotyp | 0.79841993 |
| 105 | MP0005666_abnormal_adipose_tissue | 0.79800586 |
| 106 | MP0005334_abnormal_fat_pad | 0.77347636 |
| 107 | MP0001958_emphysema | 0.77343060 |
| 108 | MP0001851_eye_inflammation | 0.76875965 |
| 109 | MP0001764_abnormal_homeostasis | 0.76311072 |
| 110 | MP0004264_abnormal_extraembryonic_tissu | 0.74724961 |
| 111 | MP0009765_abnormal_xenobiotic_induced | 0.74380648 |
| 112 | MP0003448_altered_tumor_morphology | 0.74352954 |
| 113 | MP0006054_spinal_hemorrhage | 0.73987166 |
| 114 | MP0001765_abnormal_ion_homeostasis | 0.73703717 |
| 115 | MP0005075_abnormal_melanosome_morpholog | 0.73330328 |
| 116 | MP0002971_abnormal_brown_adipose | 0.73311087 |
| 117 | MP0002277_abnormal_respiratory_mucosa | 0.73151019 |
| 118 | MP0008874_decreased_physiological_sensi | 0.72086261 |
| 119 | MP0000598_abnormal_liver_morphology | 0.69358532 |
| 120 | MP0008004_abnormal_stomach_pH | 0.67898722 |
| 121 | MP0009115_abnormal_fat_cell | 0.67512232 |
| 122 | MP0001663_abnormal_digestive_system | 0.67045785 |
| 123 | MP0003221_abnormal_cardiomyocyte_apopto | 0.66572245 |
| 124 | MP0005388_respiratory_system_phenotype | 0.65108431 |
| 125 | MP0002133_abnormal_respiratory_system | 0.65108431 |
| 126 | MP0001986_abnormal_taste_sensitivity | 0.63549951 |
| 127 | MP0002019_abnormal_tumor_incidence | 0.62205984 |
| 128 | MP0005076_abnormal_cell_differentiation | 0.62078477 |
| 129 | MP0003795_abnormal_bone_structure | 0.59478185 |
| 130 | MP0005390_skeleton_phenotype | 0.57650991 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Gastrointestinal infarctions (HP:0005244) | 4.12489898 |
| 2 | Stomatitis (HP:0010280) | 3.82472664 |
| 3 | Hyperlipoproteinemia (HP:0010980) | 3.58740885 |
| 4 | Abnormality of T cell number (HP:0011839) | 3.39983752 |
| 5 | T lymphocytopenia (HP:0005403) | 3.38165904 |
| 6 | Deep venous thrombosis (HP:0002625) | 3.36418315 |
| 7 | Pustule (HP:0200039) | 3.35596648 |
| 8 | Mediastinal lymphadenopathy (HP:0100721) | 3.24694038 |
| 9 | Chronic otitis media (HP:0000389) | 3.22335215 |
| 10 | Intrahepatic cholestasis (HP:0001406) | 3.21728816 |
| 11 | Gingivitis (HP:0000230) | 3.19290342 |
| 12 | Nasal polyposis (HP:0100582) | 3.17887041 |
| 13 | Myositis (HP:0100614) | 3.15348772 |
| 14 | Recurrent bronchitis (HP:0002837) | 3.08508777 |
| 15 | Xanthomatosis (HP:0000991) | 3.05225533 |
| 16 | Leukocytosis (HP:0001974) | 2.97621355 |
| 17 | Increased IgE level (HP:0003212) | 2.96875714 |
| 18 | Papilledema (HP:0001085) | 2.94973254 |
| 19 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.92720202 |
| 20 | IgM deficiency (HP:0002850) | 2.92673082 |
| 21 | Abnormality of the nasal mucosa (HP:0000433) | 2.88995949 |
| 22 | Gingival bleeding (HP:0000225) | 2.85881153 |
| 23 | Granulocytopenia (HP:0001913) | 2.85626505 |
| 24 | Chronic obstructive pulmonary disease (HP:0006510) | 2.84638947 |
| 25 | Obstructive lung disease (HP:0006536) | 2.84638947 |
| 26 | Recurrent viral infections (HP:0004429) | 2.82983159 |
| 27 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.81203178 |
| 28 | Recurrent fungal infections (HP:0002841) | 2.81158411 |
| 29 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.71149098 |
| 30 | Arterial thrombosis (HP:0004420) | 2.68559388 |
| 31 | Abnormality of the fingertips (HP:0001211) | 2.68320328 |
| 32 | Pulmonary embolism (HP:0002204) | 2.66676794 |
| 33 | Ketosis (HP:0001946) | 2.60286456 |
| 34 | Cellulitis (HP:0100658) | 2.60263358 |
| 35 | Eosinophilia (HP:0001880) | 2.59277563 |
| 36 | Orchitis (HP:0100796) | 2.54557817 |
| 37 | Hypoalphalipoproteinemia (HP:0003233) | 2.51804359 |
| 38 | Slow saccadic eye movements (HP:0000514) | 2.51784116 |
| 39 | Abnormality of the common coagulation pathway (HP:0010990) | 2.50998827 |
| 40 | Retrobulbar optic neuritis (HP:0100654) | 2.50050560 |
| 41 | Optic neuritis (HP:0100653) | 2.50050560 |
| 42 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.49228647 |
| 43 | Complement deficiency (HP:0004431) | 2.48406880 |
| 44 | Autoimmune hemolytic anemia (HP:0001890) | 2.46377037 |
| 45 | Autoimmune thrombocytopenia (HP:0001973) | 2.45706528 |
| 46 | IgG deficiency (HP:0004315) | 2.43095411 |
| 47 | Abnormality of T cells (HP:0002843) | 2.42304376 |
| 48 | Eczematoid dermatitis (HP:0000976) | 2.41636188 |
| 49 | Exercise-induced myalgia (HP:0003738) | 2.39932989 |
| 50 | Inflammation of the large intestine (HP:0002037) | 2.38982504 |
| 51 | Gastrointestinal stroma tumor (HP:0100723) | 2.37724911 |
| 52 | Epistaxis (HP:0000421) | 2.37614267 |
| 53 | Vasculitis (HP:0002633) | 2.36952125 |
| 54 | Mitral stenosis (HP:0001718) | 2.35974015 |
| 55 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.29635943 |
| 56 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.29255717 |
| 57 | Chronic diarrhea (HP:0002028) | 2.27889345 |
| 58 | Urticaria (HP:0001025) | 2.27770142 |
| 59 | Macroorchidism (HP:0000053) | 2.25708363 |
| 60 | Combined immunodeficiency (HP:0005387) | 2.25682324 |
| 61 | Aortic aneurysm (HP:0004942) | 2.25034331 |
| 62 | Spontaneous hematomas (HP:0007420) | 2.23866277 |
| 63 | Gastrointestinal inflammation (HP:0004386) | 2.22663352 |
| 64 | Colitis (HP:0002583) | 2.18817186 |
| 65 | Prolonged bleeding time (HP:0003010) | 2.17905673 |
| 66 | Osteomyelitis (HP:0002754) | 2.17731789 |
| 67 | Recurrent skin infections (HP:0001581) | 2.17042635 |
| 68 | Increased IgM level (HP:0003496) | 2.15742893 |
| 69 | Ketoacidosis (HP:0001993) | 2.15174659 |
| 70 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.14294029 |
| 71 | Hypoplasia of the thymus (HP:0000778) | 2.13920187 |
| 72 | Joint hemorrhage (HP:0005261) | 2.13430498 |
| 73 | Recurrent cutaneous fungal infections (HP:0011370) | 2.13378998 |
| 74 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.13378998 |
| 75 | Recurrent bacterial skin infections (HP:0005406) | 2.12021663 |
| 76 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.11914390 |
| 77 | Peritonitis (HP:0002586) | 2.11730912 |
| 78 | Acute hepatic failure (HP:0006554) | 2.11363382 |
| 79 | Pulmonary infiltrates (HP:0002113) | 2.10707916 |
| 80 | Meningitis (HP:0001287) | 2.08858809 |
| 81 | Impaired platelet aggregation (HP:0003540) | 2.08682762 |
| 82 | Abnormal platelet function (HP:0011869) | 2.08682762 |
| 83 | Hypolipoproteinemia (HP:0010981) | 2.07181026 |
| 84 | Anorexia (HP:0002039) | 2.05813367 |
| 85 | Panhypogammaglobulinemia (HP:0003139) | 2.03555634 |
| 86 | Thyroiditis (HP:0100646) | 2.03437583 |
| 87 | Keratoconjunctivitis sicca (HP:0001097) | 2.03153435 |
| 88 | Viral hepatitis (HP:0006562) | 2.02342118 |
| 89 | Hypochromic anemia (HP:0001931) | 2.00787969 |
| 90 | Subacute progressive viral hepatitis (HP:0006572) | 2.00432796 |
| 91 | Papilloma (HP:0012740) | 1.99507989 |
| 92 | Verrucae (HP:0200043) | 1.99507989 |
| 93 | Gangrene (HP:0100758) | 1.98211188 |
| 94 | Fatigue (HP:0012378) | 1.98163581 |
| 95 | Hyperammonemia (HP:0001987) | 1.96336105 |
| 96 | Periodontitis (HP:0000704) | 1.96027650 |
| 97 | Hypergammaglobulinemia (HP:0010702) | 1.95790719 |
| 98 | Hypochromic microcytic anemia (HP:0004840) | 1.95323866 |
| 99 | Agammaglobulinemia (HP:0004432) | 1.95133036 |
| 100 | Thrombophlebitis (HP:0004418) | 1.95059928 |
| 101 | Abnormality of the pleura (HP:0002103) | 1.93988928 |
| 102 | Myocardial infarction (HP:0001658) | 1.93612993 |
| 103 | Sepsis (HP:0100806) | 1.93446522 |
| 104 | B lymphocytopenia (HP:0010976) | 1.93105687 |
| 105 | Abnormality of B cell number (HP:0010975) | 1.93105687 |
| 106 | Prolonged partial thromboplastin time (HP:0003645) | 1.92634739 |
| 107 | Facial diplegia (HP:0001349) | 1.92556419 |
| 108 | Recurrent abscess formation (HP:0002722) | 1.91964295 |
| 109 | Abnormality of the peritoneum (HP:0002585) | 1.91901453 |
| 110 | Encephalitis (HP:0002383) | 1.91541686 |
| 111 | Abnormality of T cell physiology (HP:0011840) | 1.90932837 |
| 112 | Recurrent sinusitis (HP:0011108) | 1.90060909 |
| 113 | Acanthocytosis (HP:0001927) | 1.89873636 |
| 114 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.88656153 |
| 115 | Joint swelling (HP:0001386) | 1.88352983 |
| 116 | Interstitial pulmonary disease (HP:0006530) | 1.87787455 |
| 117 | Bronchitis (HP:0012387) | 1.87617461 |
| 118 | Hypertriglyceridemia (HP:0002155) | 1.85933271 |
| 119 | Abnormality of macrophages (HP:0004311) | 1.85514124 |
| 120 | Glomerulopathy (HP:0100820) | 1.84961152 |
| 121 | Hematochezia (HP:0002573) | 1.83448302 |
| 122 | Hypercholesterolemia (HP:0003124) | 1.82517511 |
| 123 | Chest pain (HP:0100749) | 1.82034058 |
| 124 | Tetraparesis (HP:0002273) | 1.81003935 |
| 125 | Lymphopenia (HP:0001888) | 1.80679848 |
| 126 | Microcytic anemia (HP:0001935) | 1.80416030 |
| 127 | Severe combined immunodeficiency (HP:0004430) | 1.80026065 |
| 128 | Keratoconjunctivitis (HP:0001096) | 1.79678134 |
| 129 | Abnormal platelet volume (HP:0011876) | 1.78617537 |
| 130 | Episodic fever (HP:0001954) | 1.78488762 |
| 131 | Skin ulcer (HP:0200042) | 1.78405288 |
| 132 | Hemoptysis (HP:0002105) | 1.78019222 |
| 133 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.77962178 |
| 134 | Hypobetalipoproteinemia (HP:0003563) | 1.76250003 |
| 135 | Spondylolisthesis (HP:0003302) | 1.75416187 |
| 136 | Myoglobinuria (HP:0002913) | 1.74843470 |
| 137 | Basal cell carcinoma (HP:0002671) | 1.74427443 |
| 138 | Asymmetric septal hypertrophy (HP:0001670) | 1.74281190 |
| 139 | Menorrhagia (HP:0000132) | 1.72986473 |
| 140 | Abnormality of eosinophils (HP:0001879) | 1.72869645 |
| 141 | Abnormality of the endocardium (HP:0004306) | 1.72862232 |
| 142 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.71522257 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 3.61908019 |
| 2 | TXK | 3.57151048 |
| 3 | PRPF4B | 2.69737903 |
| 4 | TRIB3 | 2.58959857 |
| 5 | FGFR4 | 2.51889803 |
| 6 | TYK2 | 2.38510040 |
| 7 | TAOK3 | 2.34049055 |
| 8 | JAK1 | 2.33922511 |
| 9 | JAK3 | 2.33780713 |
| 10 | PKN2 | 2.25960320 |
| 11 | ITK | 1.93538959 |
| 12 | FGFR3 | 1.84654554 |
| 13 | IKBKE | 1.81685182 |
| 14 | EPHB1 | 1.80306637 |
| 15 | KIT | 1.78697408 |
| 16 | SIK1 | 1.78551501 |
| 17 | MAP3K7 | 1.73660577 |
| 18 | ZAP70 | 1.64151994 |
| 19 | TBK1 | 1.64071465 |
| 20 | STK10 | 1.61316268 |
| 21 | MAP3K14 | 1.53097348 |
| 22 | MAP3K13 | 1.52771853 |
| 23 | ERN1 | 1.45713599 |
| 24 | EEF2K | 1.38614214 |
| 25 | TGFBR2 | 1.36163917 |
| 26 | FGFR2 | 1.33538865 |
| 27 | CSF1R | 1.33115759 |
| 28 | TTN | 1.30806264 |
| 29 | BTK | 1.27042139 |
| 30 | DMPK | 1.26595579 |
| 31 | PRKCH | 1.25370793 |
| 32 | GRK6 | 1.24598980 |
| 33 | SGK3 | 1.24276612 |
| 34 | PTK6 | 1.23523350 |
| 35 | LRRK2 | 1.23080086 |
| 36 | FGR | 1.21522151 |
| 37 | LCK | 1.21112059 |
| 38 | PRKCQ | 1.20239825 |
| 39 | NEK9 | 1.19230731 |
| 40 | YES1 | 1.17213835 |
| 41 | KSR2 | 1.16968399 |
| 42 | MAPK12 | 1.16182959 |
| 43 | JAK2 | 1.15407284 |
| 44 | CAMK1G | 1.14674123 |
| 45 | CSK | 1.13689664 |
| 46 | MAP2K3 | 1.13001399 |
| 47 | FLT3 | 1.12265249 |
| 48 | TNK2 | 1.09211117 |
| 49 | SIK3 | 1.08717596 |
| 50 | SYK | 1.08223570 |
| 51 | BMPR2 | 1.07475921 |
| 52 | HCK | 1.03975030 |
| 53 | BCKDK | 1.03499002 |
| 54 | MAP3K2 | 1.03266281 |
| 55 | FES | 1.03083893 |
| 56 | CAMK1D | 1.02331555 |
| 57 | CDK12 | 1.01626817 |
| 58 | MAP3K1 | 1.00808488 |
| 59 | TEC | 0.99072817 |
| 60 | PDK1 | 0.98692963 |
| 61 | MAP3K3 | 0.96199029 |
| 62 | RIPK1 | 0.95448720 |
| 63 | IRAK3 | 0.94133891 |
| 64 | MAPK7 | 0.92837065 |
| 65 | FRK | 0.91802620 |
| 66 | PIK3CG | 0.86936054 |
| 67 | STK38 | 0.85188025 |
| 68 | WNK1 | 0.82776313 |
| 69 | RET | 0.82020329 |
| 70 | TAOK1 | 0.80472360 |
| 71 | IKBKB | 0.79820054 |
| 72 | IRAK4 | 0.78504843 |
| 73 | PASK | 0.78118938 |
| 74 | MAP3K6 | 0.77402261 |
| 75 | MAPK11 | 0.76356737 |
| 76 | IRAK1 | 0.76136763 |
| 77 | EPHA3 | 0.76006385 |
| 78 | SGK2 | 0.75828395 |
| 79 | PDGFRB | 0.74669250 |
| 80 | CDK9 | 0.73246859 |
| 81 | STK24 | 0.72963235 |
| 82 | BLK | 0.71930361 |
| 83 | CDC42BPA | 0.71614777 |
| 84 | PIM1 | 0.67653395 |
| 85 | PTK2B | 0.65975083 |
| 86 | BRD4 | 0.65939351 |
| 87 | INSRR | 0.65909036 |
| 88 | PRKAA2 | 0.65003337 |
| 89 | CAMKK1 | 0.63948568 |
| 90 | HIPK2 | 0.63342031 |
| 91 | SIK2 | 0.62986714 |
| 92 | PDPK1 | 0.62575024 |
| 93 | MARK3 | 0.61518254 |
| 94 | DYRK1B | 0.59413312 |
| 95 | PIK3CA | 0.56885244 |
| 96 | MAP3K10 | 0.56240354 |
| 97 | MAP2K2 | 0.54281871 |
| 98 | TNIK | 0.53634697 |
| 99 | MELK | 0.52822519 |
| 100 | CAMKK2 | 0.52537849 |
| 101 | MAPK4 | 0.50881530 |
| 102 | IGF1R | 0.50182988 |
| 103 | SGK223 | 0.49939314 |
| 104 | SGK494 | 0.49939314 |
| 105 | FYN | 0.49572655 |
| 106 | LYN | 0.48348528 |
| 107 | CHUK | 0.48279800 |
| 108 | TRPM7 | 0.47921175 |
| 109 | MARK2 | 0.46680721 |
| 110 | PRKD2 | 0.45294503 |
| 111 | PRKD1 | 0.45263763 |
| 112 | STK11 | 0.44925232 |
| 113 | MAPKAPK5 | 0.44354652 |
| 114 | MAP2K6 | 0.43286311 |
| 115 | RAF1 | 0.42482554 |
| 116 | STK39 | 0.42105002 |
| 117 | TYRO3 | 0.41318357 |
| 118 | NLK | 0.41317928 |
| 119 | KSR1 | 0.40582224 |
| 120 | PHKG1 | 0.40024822 |
| 121 | PHKG2 | 0.40024822 |
| 122 | MAPK15 | 0.37887268 |
| 123 | IRAK2 | 0.37591622 |
| 124 | RIPK4 | 0.36841249 |
| 125 | FGFR1 | 0.36645737 |
| 126 | LMTK2 | 0.36023177 |
| 127 | MAP3K11 | 0.35227135 |
| 128 | MATK | 0.34958099 |
| 129 | CAMK4 | 0.34556809 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.65043681 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.33334448 |
| 3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.25842568 |
| 4 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.19912437 |
| 5 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.11597714 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.01616679 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.80868576 |
| 8 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.78448765 |
| 9 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.69714869 |
| 10 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.69474058 |
| 11 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.66142510 |
| 12 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.66052024 |
| 13 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.64633019 |
| 14 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.63690875 |
| 15 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.61975179 |
| 16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.59681703 |
| 17 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.56778217 |
| 18 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.53046720 |
| 19 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.50687329 |
| 20 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.49837149 |
| 21 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.47453002 |
| 22 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.43806607 |
| 23 | ABC transporters_Homo sapiens_hsa02010 | 1.38808787 |
| 24 | Lysine degradation_Homo sapiens_hsa00310 | 1.37105160 |
| 25 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.32588258 |
| 26 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.30246653 |
| 27 | Influenza A_Homo sapiens_hsa05164 | 1.25510078 |
| 28 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.24826837 |
| 29 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.22159603 |
| 30 | Bile secretion_Homo sapiens_hsa04976 | 1.21655378 |
| 31 | Leishmaniasis_Homo sapiens_hsa05140 | 1.11824863 |
| 32 | Peroxisome_Homo sapiens_hsa04146 | 1.09379806 |
| 33 | Measles_Homo sapiens_hsa05162 | 1.09328473 |
| 34 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.09047101 |
| 35 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.08168172 |
| 36 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.07622095 |
| 37 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.07219952 |
| 38 | Endometrial cancer_Homo sapiens_hsa05213 | 1.03053149 |
| 39 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.02260863 |
| 40 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.01908057 |
| 41 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.01762264 |
| 42 | Insulin resistance_Homo sapiens_hsa04931 | 1.00462038 |
| 43 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.98060019 |
| 44 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.97570313 |
| 45 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.96650719 |
| 46 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.96570376 |
| 47 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.93231554 |
| 48 | * FoxO signaling pathway_Homo sapiens_hsa04068 | 0.92909381 |
| 49 | Platelet activation_Homo sapiens_hsa04611 | 0.88747670 |
| 50 | Colorectal cancer_Homo sapiens_hsa05210 | 0.87023870 |
| 51 | Apoptosis_Homo sapiens_hsa04210 | 0.86840681 |
| 52 | Allograft rejection_Homo sapiens_hsa05330 | 0.84197642 |
| 53 | Legionellosis_Homo sapiens_hsa05134 | 0.84040860 |
| 54 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.83829219 |
| 55 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.83024423 |
| 56 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.80852010 |
| 57 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.78120415 |
| 58 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.77391763 |
| 59 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.76929988 |
| 60 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.76825020 |
| 61 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.75696733 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.75447915 |
| 63 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.74967721 |
| 64 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.74735369 |
| 65 | Prostate cancer_Homo sapiens_hsa05215 | 0.74490569 |
| 66 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.73883693 |
| 67 | Pertussis_Homo sapiens_hsa05133 | 0.73812173 |
| 68 | Asthma_Homo sapiens_hsa05310 | 0.73702853 |
| 69 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.72922408 |
| 70 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.72720191 |
| 71 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.72596457 |
| 72 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.72509135 |
| 73 | Shigellosis_Homo sapiens_hsa05131 | 0.70701988 |
| 74 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.70010149 |
| 75 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.69428580 |
| 76 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.68776240 |
| 77 | Histidine metabolism_Homo sapiens_hsa00340 | 0.67643018 |
| 78 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.67419638 |
| 79 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.67412516 |
| 80 | HTLV-I infection_Homo sapiens_hsa05166 | 0.66709601 |
| 81 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.66484334 |
| 82 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.65766285 |
| 83 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.65608663 |
| 84 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.64970934 |
| 85 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.64942352 |
| 86 | Long-term potentiation_Homo sapiens_hsa04720 | 0.63125933 |
| 87 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.62963199 |
| 88 | Phagosome_Homo sapiens_hsa04145 | 0.61326109 |
| 89 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.60227352 |
| 90 | * Viral carcinogenesis_Homo sapiens_hsa05203 | 0.59787043 |
| 91 | Glioma_Homo sapiens_hsa05214 | 0.59786133 |
| 92 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.59770272 |
| 93 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.59301272 |
| 94 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.58739025 |
| 95 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.57930227 |
| 96 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.57856356 |
| 97 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.56904047 |
| 98 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.56428703 |
| 99 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.54496142 |
| 100 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.54427166 |
| 101 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.54340574 |
| 102 | Viral myocarditis_Homo sapiens_hsa05416 | 0.54169609 |
| 103 | Thyroid cancer_Homo sapiens_hsa05216 | 0.52841612 |
| 104 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.51968518 |
| 105 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.51813237 |
| 106 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.51800763 |
| 107 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.51739009 |
| 108 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.51122963 |
| 109 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.50751085 |
| 110 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.50599609 |
| 111 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.48841127 |
| 112 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.48578506 |
| 113 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.48038407 |
| 114 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.47698821 |
| 115 | Amoebiasis_Homo sapiens_hsa05146 | 0.47666234 |
| 116 | Retinol metabolism_Homo sapiens_hsa00830 | 0.47367019 |
| 117 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.47299070 |
| 118 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.46577335 |
| 119 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.45842387 |
| 120 | Other glycan degradation_Homo sapiens_hsa00511 | 0.45581524 |
| 121 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.45489241 |
| 122 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.45418736 |
| 123 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.44609094 |
| 124 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.43917341 |
| 125 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.43346947 |
| 126 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.42289556 |
| 127 | Circadian rhythm_Homo sapiens_hsa04710 | 0.42028702 |
| 128 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.41946782 |
| 129 | Hepatitis C_Homo sapiens_hsa05160 | 0.41680982 |
| 130 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.41404267 |
| 131 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.41270643 |
| 132 | Salmonella infection_Homo sapiens_hsa05132 | 0.40633977 |
| 133 | Malaria_Homo sapiens_hsa05144 | 0.39886005 |
| 134 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.39538708 |
| 135 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.39307694 |
| 136 | Tuberculosis_Homo sapiens_hsa05152 | 0.39129123 |
| 137 | Endocytosis_Homo sapiens_hsa04144 | 0.38888785 |
| 138 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.38570014 |
| 139 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.38135129 |
| 140 | Hepatitis B_Homo sapiens_hsa05161 | 0.38095263 |
| 141 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.38021413 |
| 142 | Renin secretion_Homo sapiens_hsa04924 | 0.37369280 |
| 143 | Carbon metabolism_Homo sapiens_hsa01200 | 0.36886134 |
| 144 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.35777234 |
| 145 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.35125570 |

